D.C. Mun. Regs. tit. 22, r. 22-B1202
Current through Register Vol. 71, No. 49, December 6, 2024
Rule 22-B1202 - SCHEDULE II ENUMERATED1202.1 The controlled substances listed in this section are included in Schedule II of the Act unless removed therefrom pursuant to Section 201 of the Act:
(a) Unless specifically excepted or unless listed in another schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis; (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextophan, nalbuphine, naltrexone, and their respective salts, but including the following: (C) Etorphine Hydrochloride;(K) Opium fluid extracts;(2) Opium: Any salt, compound, derivative, or preparation thereof that is chemically equivalent or identical with any of the substances referred to in subparagraph (1) of this paragraph, but not including the isoquinoline alkaloids of opium;(3) Opium poppy or poppy straw;(4) Coca leaves, except coca leaves or extracts of coca leaves from which cocaine, ecgonine, or derivatives of ecgonine or their salts have been removed; cocaine, its salts, optical and geometric isomers, salts of isomers; or any compound, mixture, or preparation that contains any substance referred to in this paragraph;(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form that contains the phenanthrene alkaloids of the opium poppy); and(b) Opiates: Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan excepted: (1) 4-anilino-N-phenethyl-4-piperidine (ANPP);(6) Bulk Dextropropoxyphene (non-dosage form);(13) Levo-alphacetylmethadol [Some other names: levo-alpha-acetylmethadol, levomethadyl acetate, LAAM];(18) Methadone-intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;(19) Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;(20) Pethidine (meperidine);(21) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine; (Meperidine intermediate-A)(22) Pethidine -Intermediate-B,ethyl-4-phenylpiperidine-4-carboxylate; (Meperidine intermediate-B);(23) Pethidine -Intermediate-C, 1-methyl-4-phenylpiperidine- 4-carboxylic acid; (Meperidine intermediate-C)(31) (Acetylfentanyl) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (32) (Butyrylfentanyl) N -(1-phenethylpiperidin-4-yl)-N-phenylbutyramide;(33) (Fluorobutylfentanyl) N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide;(34) (Hydroxythiofentanyl) N-(1-(2-Hydroxy-2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-pheny1propanamide ;(35) (Isobutyrfentanyl) N-(1-Phenethylpiperidin-4-y1)-N-phenylisobutyramide;(36) (Ocfentanil) N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide; N-(2-Fluorophenyl)-2-methoxy-N-(1-(2-phenylethyl)-4-piperidinyl)acetamide; (37) 2-(1,3-dimethoxybuta-1,3-dien-2-yl)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine; (38) (2a,4aR,6aR,7R,9S,10aS10bR)-methyl-9-acetoxy-2 (furan-3-yl)-6a,10b-dimethyl-4,10-dioxododecahydro-1H-benzo[f]isochromene -7-carboxylate;(39) 4,5-epoxy-17-methylmorphinan-3-ol;(40) N-phenyl-N-[1-(2-phenethyl)-4-piperidinyl] acetamide;(41) N-(1-benzylpiperidin-4-yl)-N-(x-fluorophenyl)-butanamide;(42) 2-methyl-N-phenyl-N-[1-(1-phenylpropan-2-yl)piperidin-4-yl]propanamide;(43) 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine;(44) N-phenyl-N-(1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)acetamide;(45) 4-chloro-N-(1-phenethylpiperidin -2-ylidene)benzenesulfonamide; and(46) 4-chloro-N-(1-(4-nitrophenethyl)piperidin-2-ylidene)benzenesulfonamide;(c) Stimulants: Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system: (1) Amphetamines, its salts, optical isomers, and salts of its optical isomers;(4) (Ethylphenidate) ethyl 2-phenyl-2-(piperdin-2-yl)acetate; (6) Methylphenidate and its salts;(7) Methamphetamine, its salts, isomers, and salts of isomers; and(8) Phenmetrazine and its salts;(d) Immediate precursors: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any (1) Amphetamine/methamphetamine immediate precursor: phenylacetone (other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone);(2) Immediate precursor to fentanyl: 4-anilino-N-phenethyl-4-piperidine (ANPP); and(e) Depressants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (f) Hallucinogenic substances: (1) Immediate precursors to phencyclidine (PCP): (A) 1-phenylcyclohexylamine;(B) 1-piperidinocyclohexanecarbonitrile (PCC); andD.C. Mun. Regs. tit. 22, r. 22-B1202
Final Rulemaking published at 39 DCR 1882, 1885 (March 20, 1992); as amended by Final Rulemaking published at 41 DCR 7967 (December 16, 1994); and by D.C. Law 8-138 §2(b)(2), 37 DCR 2638 (June 13, 1990); Notice of Emergency and Proposed Rulemaking published at 47 DCR 7512 (September 15, 2000) [EXPIRED]; as amended by Final Rulemaking published at 48 DCR 914 (February 2, 2001); as amended by Notice of Emergency and Proposed Rulemaking published at 50 DCR 10421 (December 5, 2003) [EXPIRED]; as amended by Final Rulemaking published at 51 DCR 4080 (April 23, 2004); as amended by Final Rulemaking published at 61 DCR 10233 (October 3, 2014); amended by Final Rulemaking published at 63 DCR 014819 (12/2/2016)